106 related articles for article (PubMed ID: 15674425)
21. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
[TBL] [Abstract][Full Text] [Related]
22. Signalling to drug resistance in CLL.
Hertlein E; Byrd JC
Best Pract Res Clin Haematol; 2010 Mar; 23(1):121-31. PubMed ID: 20620976
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
[TBL] [Abstract][Full Text] [Related]
24. Cytoprotective antioxidant activity of serum albumin and autocrine catalase in chronic lymphocytic leukaemia.
Moran EC; Kamiguti AS; Cawley JC; Pettitt AR
Br J Haematol; 2002 Feb; 116(2):316-28. PubMed ID: 11841432
[TBL] [Abstract][Full Text] [Related]
25. CD154 gene therapy for human B-cell malignancies.
Messmer D; Kipps TJ
Ann N Y Acad Sci; 2005 Dec; 1062():51-60. PubMed ID: 16461788
[TBL] [Abstract][Full Text] [Related]
26. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells.
Dai Y; Chen S; Kramer LB; Funk VL; Dent P; Grant S
Clin Cancer Res; 2008 Jan; 14(2):549-58. PubMed ID: 18223231
[TBL] [Abstract][Full Text] [Related]
27. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
Dicker F; Kater AP; Prada CE; Fukuda T; Castro JE; Sun G; Wang JY; Kipps TJ
Blood; 2006 Nov; 108(10):3450-7. PubMed ID: 16741250
[TBL] [Abstract][Full Text] [Related]
28. Circulating vascular endothelial growth factor (VEGF) and its soluble receptors in patients with chronic lymphocytic leukemia.
Gora-Tybor J; Blonski JZ; Robak T
Eur Cytokine Netw; 2005; 16(1):41-6. PubMed ID: 15809205
[TBL] [Abstract][Full Text] [Related]
29. The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine.
Hewamana S; Lin TT; Jenkins C; Burnett AK; Jordan CT; Fegan C; Brennan P; Rowntree C; Pepper C
Clin Cancer Res; 2008 Dec; 14(24):8102-11. PubMed ID: 19088025
[TBL] [Abstract][Full Text] [Related]
30. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.
Willimott S; Baou M; Huf S; Deaglio S; Wagner SD
Haematologica; 2007 Oct; 92(10):1359-66. PubMed ID: 18024373
[TBL] [Abstract][Full Text] [Related]
31. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma.
Plander M; Ugocsai P; Seegers S; Orsó E; Reichle A; Schmitz G; Hofstädter F; Brockhoff G
Ann Hematol; 2011 Dec; 90(12):1381-90. PubMed ID: 21465189
[TBL] [Abstract][Full Text] [Related]
32. In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.
Battle TE; Wierda WG; Rassenti LZ; Zahrieh D; Neuberg D; Kipps TJ; Frank DA
Clin Cancer Res; 2003 Jun; 9(6):2166-72. PubMed ID: 12796382
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.
Kumar SA; Hu X; Brown M; Kuschak B; Hernandez TA; Johnston JB; Gibson SB
Leuk Lymphoma; 2009 Dec; 50(12):2038-48. PubMed ID: 19860625
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cells.
Gehrke I; Gandhirajan RK; Poll-Wolbeck SJ; Hallek M; Kreuzer KA
Mol Med; 2011; 17(7-8):619-27. PubMed ID: 21519633
[TBL] [Abstract][Full Text] [Related]
35. CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium.
Till KJ; Spiller DG; Harris RJ; Chen H; Zuzel M; Cawley JC
Blood; 2005 Jun; 105(12):4813-9. PubMed ID: 15731179
[TBL] [Abstract][Full Text] [Related]
36. Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.
Hayden RE; Pratt G; Davies NJ; Khanim FL; Birtwistle J; Delgado J; Pearce C; Sant T; Drayson MT; Bunce CM
Leukemia; 2009 Feb; 23(2):292-304. PubMed ID: 18923439
[TBL] [Abstract][Full Text] [Related]
37. Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6.
Bhattacharya N; Reichenzeller M; Caudron-Herger M; Haebe S; Brady N; Diener S; Nothing M; Döhner H; Stilgenbauer S; Rippe K; Mertens D
Int J Cancer; 2015 Jan; 136(1):65-73. PubMed ID: 24828787
[TBL] [Abstract][Full Text] [Related]
38. CD137 is induced by the CD40 signal on chronic lymphocytic leukemia B cells and transduces the survival signal via NF-κB activation.
Nakaima Y; Watanabe K; Koyama T; Miura O; Fukuda T
PLoS One; 2013; 8(5):e64425. PubMed ID: 23696891
[TBL] [Abstract][Full Text] [Related]
39. Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways.
Santos SC; Dias S
Blood; 2004 May; 103(10):3883-9. PubMed ID: 14726393
[TBL] [Abstract][Full Text] [Related]
40. Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia.
Chapman EA; Oates M; Mohammad IS; Davies BR; Stockman PK; Zhuang J; Pettitt AR
Oncotarget; 2017 Nov; 8(61):102948-102964. PubMed ID: 29262536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
